NEXT LIQUID EXOME
associated with 48 other trademarks
Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagno...

Words that describe this trademark:

Serial Number:

97682924

Mark:

NEXT LIQUID EXOME

Status:

Notice of Allowance-Issued

Status Date:

06-04-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Servicemark

Published for Opposition Date:

04-02-2024

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

1001 WEST FOURTH STREET

Recent Trademark filings by this company